KUALA LUMPUR Jan 1 — Preliminary results of a study conducted by the Pontifical Catholic University in Chile (UC) showed that the Covid-19 Sinovac vaccine booster dose could activate cellular immunity against the Omicron variant, on subjects who were given two doses of the same vaccine previously.